Found: 2
Select item for more details and to access through your institution.
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real‐world multicenter cohort study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 7, p. 627, doi. 10.1111/hepr.14021
- By:
- Publication type:
- Article
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B.
- Published in:
- Journal of Medical Virology, 2024, v. 96, n. 7, p. 1, doi. 10.1002/jmv.29760
- By:
- Publication type:
- Article